Quick Links

Faculty of Medicine news

Key mechanism identified in brain tumor growth

A gene known as OSMR plays a key role in driving the growth of glioblastoma tumors, according to a new study led by a McGill University researcher and published in the journal Nature Neuroscience. Glioblastoma is the most aggressive type of brain tumor in adults. Unfortunately, there are no effective treatments for the disease. On average, patients succumb just 16 months after diagnosis.

Published on : 25 Apr 2016

$1.2 M for McGill from CFI John R. Evans Leaders Fund

On April 15, the Canada Foundation for Innovation (CFI) announced a new round of research investment that is bringing $1.2 million to McGill. In total, six McGill research projects will be funded, covering subjects ranging from the creation of a mobile ecology lab for the study of Arctic environmental change to studying the underlying processes behind the pain that comes from doing physical exercise.

Published on : 15 Apr 2016

McGill gets $1.65 M from NSERC for training project

McGill Newsroom CREATE project to prepare graduates for high-skills work in surgical-devices industry A team led by McGill University professor Jake Barralet will receive $1.65 million from the Natural Sciences and Engineering Research Council of Canada to provide nearly 90 students with cross-disciplinary training to prepare them for high-skill jobs in the surgical devices industry.

Published on : 14 Apr 2016

How depression may compound risk of type 2 diabetes

McGill Newsroom Depression, metabolic factors combine to boost risk of developing diabetes, study finds  Depression may compound the risk of developing type 2 diabetes in people with early warning signs of metabolic disease, according to researchers from McGill University, l'Université de Montréal, the Institut de recherches cliniques de Montréal and the University of Calgary.

Published on : 12 Apr 2016

HIV target shows surprising resistance

By Tod Hoffman, Lady Davis Institute  Research reveals that even a tiny mutation can allow the HIV virus to become resistant to therapies using the CRISPR/Cas9 gene-editing platform

Published on : 08 Apr 2016

RI-MUHC leads innovative network to support children

McGill University Health Centre RI-MUHC will lead an innovative pan-Canadian network that aims to improve life outcomes for children with brain-based development disabilities RI-MUHC will lead an innovative pan-Canadian network that aims to improve life outcomes for children with brain-based development disabilities

Published on : 31 Mar 2016

Longer maternity leave linked to better infant health

McGill Newsroom McGill, UCLA study of low- and middle-income countries shows paid maternity leave policies could help prevent infant deaths For each additional month of paid maternity leave offered in low- and middle-income countries (LMICs), infant mortality is reduced by 13%, according to a new study by researchers from McGill University and UCLA Fielding School of Public Health.

Published on : 30 Mar 2016

No increased heart failure with incretin-based drugs

McGill Newsroom Canadian drug safety network provides reassuring evidence regarding risk of heart failure of anti-diabetes medications Incretin-based drugs, a type of medication used to treat type 2 diabetes, do not increase the risk of being hospitalized for heart failure relative to commonly used combinations of oral anti-diabetic drugs, according to a new study published in the New England Journal of Medicine.

Published on : 24 Mar 2016

Teens test their smarts in the Brain Bee

By Maya-Olivia Eyssen, Montreal Neurological Institute and Hospital Montreal high school students to take part in brain quiz.

Published on : 09 Mar 2016

"Smart soles" help patients recover from a broken hip

By Julie Robert, McGill University Health Centre Hip fractures are one of the most common injuries sustained by the elderly population following a fall.

Published on : 04 Mar 2016

What makes the brain tick so fast?

By Chris Chipello, McGill Newsroom Surprisingly complex interactions between neurotransmitter receptors and other key proteins help explain the brain’s ability to process information with lightning speed, according to a new study.

Published on : 25 Feb 2016

Diabetes drug found not to cause pancreatic cancer

By Tod Hoffman, Lady Davis Institute for Medical Research The use of incretin-based drugs is not associated with an increased risk of pancreatic cancer in patients with type 2 diabetes, according to a study published in the latest issue of the British Medical Journal (BMJ). The research was conducted by the Canadian Network for Observational Drug Effect Studies (CNODES), which used the health records of almost 1 million patients with types 2 diabetes.

Published on : 22 Feb 2016